DOJ's Bureau of Prisons awards $2.7M for inmate/staff flu shots to Sanofi Vaccines US Inc
Contract Overview
Contract Amount: $2,732 ($2.7K)
Contractor: Sanofi Vaccines US Inc.
Awarding Agency: Department of Justice
Start Date: 2026-04-02
End Date: 2026-09-15
Contract Duration: 166 days
Daily Burn Rate: $16/day
Competition Type: FULL AND OPEN COMPETITION
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: FLU SHOTS (INMATE AND STAFF) FY 2026
Place of Performance
Location: SWIFTWATER, MONROE County, PENNSYLVANIA, 18370
Plain-Language Summary
Department of Justice obligated $2,732.22 to SANOFI VACCINES US INC. for work described as: FLU SHOTS (INMATE AND STAFF) FY 2026 Key points: 1. The contract is for essential healthcare supplies, specifically flu vaccinations. 2. Sanofi Vaccines US Inc. is a significant player in the vaccine market. 3. The primary risk involves potential supply chain disruptions or vaccine efficacy issues. 4. This falls within the Pharmaceutical Preparation Manufacturing sector.
Value Assessment
Rating: fair
The award amount of $2.73M for 166 days of service appears reasonable given the need for mass vaccination. Benchmarking against similar large-scale public health procurements would provide a clearer picture of value.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, suggesting a competitive bidding process. This method is generally effective in achieving fair market prices.
Taxpayer Impact: Taxpayer funds are being used for essential public health services within federal correctional facilities, aiming to prevent widespread illness and associated costs.
Public Impact
Ensures health and safety of inmates and correctional staff. Reduces potential outbreaks and associated healthcare burdens within facilities. Supports national public health initiatives by providing vaccinations.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Potential for price increases in subsequent years.
- Dependence on a single supplier for a critical health commodity.
Positive Signals
- Proactive health measure for a vulnerable population.
- Competitive bidding process likely secured a fair price.
Sector Analysis
The pharmaceutical and vaccine sector is characterized by high R&D costs, stringent regulatory oversight, and significant market concentration. Federal spending in this area often focuses on public health needs and strategic stockpiling.
Small Business Impact
This contract does not appear to involve small business participation, as it was awarded to a large corporation. Opportunities for small businesses in pharmaceutical manufacturing and distribution may exist in other federal contracts.
Oversight & Accountability
The Bureau of Prisons is responsible for managing this contract. Oversight should focus on timely delivery, quality of vaccines, and adherence to the firm fixed price.
Related Government Programs
- Pharmaceutical Preparation Manufacturing
- Department of Justice Contracting
- Federal Prison System / Bureau of Prisons Programs
Risk Flags
- Potential for price escalation in future contract periods.
- Reliance on a single manufacturer for a critical public health need.
- Vulnerability to global supply chain disruptions affecting vaccine availability.
- Ensuring adequate cold chain logistics for vaccine storage and transport.
Tags
pharmaceutical-preparation-manufacturing, department-of-justice, pa, delivery-order, under-100k
Frequently Asked Questions
What is this federal contract paying for?
Department of Justice awarded $2,732.22 to SANOFI VACCINES US INC.. FLU SHOTS (INMATE AND STAFF) FY 2026
Who is the contractor on this award?
The obligated recipient is SANOFI VACCINES US INC..
Which agency awarded this contract?
Awarding agency: Department of Justice (Federal Prison System / Bureau of Prisons).
What is the total obligated amount?
The obligated amount is $2,732.22.
What is the period of performance?
Start: 2026-04-02. End: 2026-09-15.
What is the historical cost per dose for similar flu vaccine procurements by federal agencies?
Historical data on per-dose costs for flu vaccines can vary significantly based on the specific vaccine type, manufacturer, volume, and contract terms. Agencies like the CDC and DoD often procure large quantities, which can drive down per-unit costs. Benchmarking against these established rates, adjusted for inflation and specific delivery requirements, would be crucial for assessing the value of this $2.73M award.
What are the contingency plans if Sanofi Vaccines US Inc. faces production or supply chain issues?
Contingency plans should address potential disruptions in vaccine supply. This could include identifying alternative suppliers, maintaining a strategic reserve, or having pre-negotiated surge capacity options. The contract's terms should ideally outline remedies or penalties for non-performance and the process for addressing supply chain failures to ensure continuity of care.
How will the effectiveness of the flu vaccination program within the Bureau of Prisons be measured?
Effectiveness can be measured through several key performance indicators. These include tracking vaccination rates among inmates and staff, monitoring influenza-like illness (ILI) rates within facilities compared to baseline or previous years, and assessing the reduction in severe illness, hospitalizations, and deaths attributed to influenza. Data collection and analysis should be robust to demonstrate program impact.
Industry Classification
NAICS: Manufacturing › Pharmaceutical and Medicine Manufacturing › Pharmaceutical Preparation Manufacturing
Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Parent Company: Sanofi
Address: 1 DISCOVERY DR, SWIFTWATER, PA, 18370
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Foreign Owned, Foreign-Owned and U.S.-Incorporated Business, Manufacturer of Goods, Not Designated a Small Business, Special Designations
Financial Breakdown
Contract Ceiling: $2,732
Exercised Options: $2,732
Current Obligation: $2,732
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES
Cost or Pricing Data: NO
Parent Contract
Parent Award PIID: 36E79726D0009
IDV Type: IDC
Timeline
Start Date: 2026-04-02
Current End Date: 2026-09-15
Potential End Date: 2026-09-15 00:00:00
Last Modified: 2026-04-02
More Contracts from Sanofi Vaccines US Inc.
- 00hcvgbc-2009-68767 - Sanofi VFC Pediatric Vaccine Contract — $737.3M (Department of Health and Human Services)
- Vaccince for Children 2010 — $709.2M (Department of Health and Human Services)
- Vaccine for Children 2011 — $640.0M (Department of Health and Human Services)
- Vacccine for Children 2008 Contract — $590.5M (Department of Health and Human Services)
- VFC 2012 — $589.8M (Department of Health and Human Services)
Other Department of Justice Contracts
- Contractor Owned and Operated Existing Correctional Facility for Approximately 3,500 LOW Security Male Inmates — $794.5M (Cornell Companies, Inc.)
- Detention Services - SAN Diego — $776.9M (THE GEO Group, Inc.)
- CO: Telly Renfroe Award of NEW Task Order Base Year Initial Funding — $616.4M (AT&T Enterprises, LLC)
- TAS 151060 - Services for the Management and Operation of a Contractor-Owned, Contractor-Operated, Correctional Facility for 2,567 Beds in Adams County, Mississippi — $574.3M (Corecivic, Inc.)
- Provide Services for the Management and Operation of a Correctional Facility in Accordance With Rfp-Pcc-0014 — $568.9M (Cornell Companies, Inc.)